EGamaSTAN S/D Immune Globulin Gamma (IgG) (Human), Preservative Free 15% to 18% Injection 10 mL

The Florida Department of Health has awarded a contract valued at $6,904.00 for the procurement of immune globulin products. The contract, identified as C6C249, covers the supply of EGamaSTAN S/D Immune Globulin Gamma (IgG) (Human), Preservative Free, in 15% to 18% concentration for intravenous injection. The contract specifies a quantity of ten units at a unit price of $690.40 per unit. The contract period extends from the award date of February 2, 2026, through the completion date of June 30, 2026.

This contract represents a routine procurement of a critical immunological therapeutic agent by the State of Florida's public health authority. The five-month contract window aligns with the timeline for delivery and utilization of the immune globulin product. As a specialized pharmaceutical item procured by the Department of Health, this supply is likely designated for administration to eligible patients requiring immunoglobulin replacement therapy or post-exposure prophylaxis as part of the state's public health services.